Biocare Medical, a leader in fully open automated instrumentation, announces a collaboration with Molecular Instruments® (MI), the inventor of the HCR™ Imaging technology.
|
[05-January-2024] |
SAN FRANCISCO, Jan. 5, 2024 /PRNewswire/ -- Biocare Medical, a leader in fully open automated instrumentation, announces a collaboration with Molecular Instruments® (MI), the inventor of the HCR™ Imaging technology. This partnership brings together Biocare Medical’s expertise in automated bioimaging systems with MI’s suite of advanced HCR™ Products, setting a new standard in automated in situ hybridization (ISH) and immunohistochemistry (IHC). Molecular Instruments®: Inventor of the HCR™ Platform: Molecular Instruments®, the market disruptor in bioimaging and ISH reagents, brings to the table their patented HCR™ Imaging technology. This technology is widely acclaimed for its array of robust features including mild sample preparation with no protease digestion, isothermal amplification at room temperature, and availability with both fluorescent and brightfield imaging. The HCR™ RNA-ISH assay, a flagship application of this technology, is optimized to preserve tissue morphology and integrates seamlessly with existing IHC/IF workflows. With HCR™ RNA-ISH, researchers can target any RNA sequence in any sample with exceptional performance, speed, and versatility. Biocare Medical’s ONCORE Pro X: A Paradigm in Automation: Recognized as a leader in automated instrumentation, Biocare Medical’s ONCORE Pro X exemplifies innovation and versatility. Designed to accommodate a wide range of assays, the ONCORE Pro X is now poised to harness the capabilities of MI’s HCR™ Platform, offering unparalleled flexibility and precision in bioimaging and ISH applications for unlimited research potential. Synergizing Strengths for Advanced Bioimaging: The integration of MI’s HCR™ Platform into Biocare Medical’s ONCORE Pro X instrument represents a synergy of strengths. Biocare Medical’s commitment to open and versatile automation perfectly complements MI’s novel approach to bioimaging. Together, they are set to redefine what is possible in automated bioimaging, expanding capabilities in academic research, drug development, and clinical diagnostics. A New Era in Bioimaging: By integrating Biocare Medical’s advanced automated instrumentation with the revolutionary HCR™ Platform from Molecular Instruments, researchers can now harness the power of the ONCORE Pro. This advancement allows for faster turnaround times and bolsters high throughput efficiency, all made possible by the comprehensive automation provided by the ONCORE Pro. With this powerful combination, targeting any RNA sequence in any sample is more efficient than ever, delivering unmatched performance, speed, and versatility. This partnership is poised to unlock new possibilities and set benchmarks in precision, efficiency, and versatility. About Biocare Medical About Molecular Instruments Press Contact: View original content to download multimedia:https://www.prnewswire.com/news-releases/biocare-medical-and-molecular-instruments-partner-to-revolutionize-automated-bioimaging-through-oncore-pro-x-and-hcr-rna-ish-assays-302026805.html SOURCE Biocare Medical |